FDA Warning Letter — Blue Horizon International
The FDA took a Warning Letter action against Blue Horizon International on May 26, 2026 (Hackensack, NJ). The action was issued by CBER and concerns biologics products.
Action Details
- Facility
- Blue Horizon International
- Date
- May 26, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Center
- CBER
- Location
- Hackensack, NJ (United States)